Table A1.
Significant associations for primary and secondary outcomes (post-minus pre-intervention) from regression analyses.
| Antecedents | Barriers | Subjective Norms | Family Trait | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YBCS * Outcomes Odds Ratio or Coefficient (p) |
Intervention 1 Tailored 2 Targeted |
Age | Race 0 White/Other 1 Black |
Education ≤High school >High school |
Caregiving 0 No, 1 Yes | Anxiety 0 No, 1 Yes | Depression: 0 No, 1 Yes | Comorbidities 0 No, 1 Yes | Income:≤$40,000, >$40,000 | Insurance 0 No, 1 Yes | Routine source of care 0 No, 1 Yes | Cost-related no access to care 0 No, 1 Yes | Distance genetic services | Perc. expect family (1–7) | Perc. expect providers (1–7) | Motivation comply family (1–7) | Motivation comply provider (1–7) | Family coherence (1–20) |
| Genetic testing and surveillance a | ||||||||||||||||||
| Had Genetic Testing | 0.4631 (0.0465) |
0.9829 (0.0478) |
||||||||||||||||
| CBE - NCCN** Guidelines |
0.9741
(0.0017) |
|||||||||||||||||
| Mammography - NCCN** Guidelines1 | 0.3223 (0.0060) |
1.7535 (0.0185) |
0.6149 (0.0222) |
|||||||||||||||
| Self-Efficacy b | ||||||||||||||||||
| Self-efficacy for genetic testing (1–7) |
−0.4797 (0.0205) | −0.7221 (0.0037) | −0.3547 (0.0020) | |||||||||||||||
| Self-efficacy for CBE (1–7) |
−0.6961
(0.0007) |
−0.1369 (0.0070) | ||||||||||||||||
| Self-efficacy for mammography (1–7)1 |
−0.8296
(0.0001) |
0.4030 (0.0457) | −0.1086 (0.0372) | 0.0987 (0.0225) | −0.1639 (0.0039) | |||||||||||||
| Intention b | ||||||||||||||||||
| Intention for genetic testing (1–7) |
0.0739
(0.0002) |
0.9838
(0.0000) |
1.0475
(0.0001) |
0.0139
(0.0000) |
−0.4903 (0.0000) | |||||||||||||
| Intention for CBE (1–7) | −0.2229 (0.0076) | −0.1780 (0.0098) | ||||||||||||||||
| Intention for Mammography (1–7)1 |
1.0522
(0.0006) |
−0.1703 (0.0323) | ||||||||||||||||
| Antecedents | Barriers | Subjective Norms | Family Trait | |||||||||||||||
|
Relative Outcomes
Odds Ratio or Coefficient (p) |
Intervention
1 Tailored 2 Targeted |
Age |
Race
0 White/Other 1 Black |
Education
≤High school >High school |
Caregiving 0 No, 1 Yes | Anxiety 0 No, 1 Yes | Depression: 0 No, 1 Yes |
Comorbidities
0 No, 1 Yes |
Income
≤$40,000, >$40,000 |
Insurance 0 No, 1 Yes |
Routine source of care
0 No, 1 Yes |
Cost-related no access to care 0 No; 1 Yes | Distance genetic services |
Perc. expect family
(1–7) |
Perc. expect providers (1–7) | Motivation comply family (1–7) | Motivation comply provider (1–7) |
Family coherence
(1–20) |
| Genetic testing and surveillance a | ||||||||||||||||||
| Had Genetic Testing | 0.0983 (0.0468) |
|||||||||||||||||
| CBE - NCCN** Guidelines | 0.3720 (0.0414) |
|||||||||||||||||
| Mammography - NCCN** Guidelines 2 | 1.0040 (0.0019) |
2.9500 (0.0273) |
3.659 (0.0147) |
0.2252 (0.0039) |
1.8172 (0.0113) |
|||||||||||||
| Self-Efficacy b | ||||||||||||||||||
| Self-efficacy for genetic testing (1–7) |
−0.7305 (0.0210) | −0.3751 (0.0016) | ||||||||||||||||
| Self-efficacy for CBE (1–7) | 0.4329 (0.0414) | −0.5037 (0.0475) | −0.2106 (0.0146) | |||||||||||||||
| Self-efficacy for mammography (1–7)2 |
−0.0431 (0.0329) | −0.8418 (0.0407) | −0.2897 (0.0337) | |||||||||||||||
| Intention b | ||||||||||||||||||
| Intention for genetic testing (1–7) |
−0.3532 (0.0048) | 0.3122 (0.0294) | ||||||||||||||||
| Intention for CBE (1–7) | −0.0088 (0.0005) | −0.2442 (0.0118) | ||||||||||||||||
| Intention for Mammography (1–7)2 |
−0.0301 (0.0089) | −1.014 (0.0129) | −1.0914 (0.0258) | −0.0089 (0.0271) | −0.3514 (0.0411) | |||||||||||||
* YBCS = young breast cancer survivor; **NCCN = National Comprehensive Cancer Network; a Logistic regression; b Linear regression; 1 Tailored n = 293; Targeted n = 382, after excluding YBCS with double mastectomy (excluded Tailored n = 31; Targeted n = 95); 2 Tailored n = 60; Targeted n = 218, after excluding relatives younger than 35 years old AND relatives between 35 to 40 with Gail lifetime risk <20% according to NCCN guidelines (excluded Tailored n = 27; Targeted n = 126). Bold = still significant after Bonferroni corrections.